Tag: nirsevimab
12 infants passed away as a result of clinical trials involving an FDA-approved RSV medication.
On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and...